Miguel Vieira Martins

6PUBLICATIONS
21CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Paediatrics not elsewhere classifiedNeonatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 01, 2026
EARLY RESPONSE AND GENETICS DEFINE RELAPSE RISK AFTER FRONTLINE BLINATUMOMAB IN CHILDHOOD B-ALL: A COHORT STUDY.

|Jul 24, 2026
Immunoglobulin Depletion and Recovery Following Blinatumomab in Infants With KMT2A-Rearranged ALL.

|Jan 08, 2026
Sustained Benefit of Blinatumomab in Infants With KMT2A-Rearranged ALL: Long-Term Outcomes, Toxicity, and Pharmacokinetics.

Miguel Vieira Martins, Paola de Lorenzo, Rishi S Kotecha

|Jan 17, 2022
Azacitidine-induced massive pericardial effusion in a child with myelodysplastic syndrome.

Miguel Fogaça da Mata, Miguel Vieira Martins, João Rato

|May 04, 2021
Diaphragmatic eventration as a first sign of Scimitar syndrome.

Miguel Vieira Martins, Duarte S Martins, Graça Oliveira

Pageof 1

Frequent Collaborators

2 joint publications

Rishi S Kotecha

2 joint publications

Karsten Nysom

2 joint publications

Jan Stary

2 joint publications

Franco Locatelli